Bangalore, India, 560085
Mycophenolate Sodium 360 mg is an immunosuppressant medication used primarily to prevent organ rejection in patients who have undergone kidney, heart, or liver transplantation. It works by inhibiting the proliferation of T and B lymphocytes, which are responsible for immune-mediated graft rejection. Mycophenolate sodium is the enteric-coated form of Mycophenolate sodium, designed to reduce gastrointestinal side effects compared to mycophenolate mofetil. It selectively inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for the synthesis of guanine nucleotides in lymphocytes, thereby suppressing immune activity. This medication is commonly prescribed in combination with corticosteroids and calcineurin inhibitors such as cyclosporine or tacrolimus as part of a comprehensive immunosuppressive regimen. It is a prescription-only medicine and must be taken under strict medical supervision due to its potent immunosuppressive effects.